Pro-oxidative activities and dose–response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro
Open Access
- 16 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 31 (5), 902-910
- https://doi.org/10.1093/carcin/bgq039
Abstract
(−)-Epigallocatechin-3-gallate (EGCG), the major polyphenol in green tea, has been shown to inhibit tumorigenesis and cancer cell growth in animal models. Nevertheless, the dose–response relationship of the inhibitory activity in vivo has not been systematically characterized. The present studies were conducted to address these issues, as well as the involvement of reactive oxygen species (ROS), in the inhibitory action of EGCG in vivo and in vitro . We characterized the inhibitory actions of EGCG against human lung cancer H1299 cells in culture and in xenograft tumors. The growth of tumors was dose dependently inhibited by EGCG at doses of 0.1, 0.3 and 0.5% in the diet. Tumor cell apoptosis and oxidative DNA damage, assessed by the formation of 8-hydroxy-2′-deoxyguanosine (8-OHdG) and phosphorylated histone 2A variant X (γ-H2AX), were dose dependently increased by EGCG treatment. However, the levels of 8-OHdG and γ-H2AX were not changed by the EGCG treatment in host organs. In culture, the growth of viable H1299 cells was dose dependently reduced by EGCG; the estimated concentration that causes 50% inhibition (IC 50 ) (20 μM) was much higher than the IC 50 (0.15 μM) observed in vivo . The action of EGCG was mostly abolished by the presence of superoxide dismutase (SOD) and catalase, which decompose the ROS formed in the culture medium. Treatment with EGCG also caused the generation of intracellular ROS and mitochondrial ROS. Although EGCG is generally considered to be an antioxidant, the present study demonstrates the pro-oxidative activities of EGCG in vivo and in vitro in the described experimental system.Keywords
This publication has 38 references indexed in Scilit:
- Dietary Chemopreventive Phytochemicals: Too Little or Too Much?Cancer Prevention Research, 2009
- Cancer prevention by tea: animal studies, molecular mechanisms and human relevanceNature Reviews Cancer, 2009
- Bioavailability issues in studying the health effects of plant polyphenolic compoundsMolecular Nutrition & Food Research, 2008
- Fyn is a novel target of (−)‐epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformationMolecular Carcinogenesis, 2007
- Direct Inhibition of Insulin-Like Growth Factor-I Receptor Kinase Activity by (−)−Epigallocatechin-3-Gallate Regulates Cell TransformationCancer Epidemiology, Biomarkers & Prevention, 2007
- (−)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer CellsClinical Cancer Research, 2005
- Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivativesBioorganic & Medicinal Chemistry Letters, 2005
- Inhibition of Carcinogenesis by TeaAnnual Review of Pharmacology and Toxicology, 2002
- Reactive oxygen species and programmed cell deathTrends in Biochemical Sciences, 1996
- Inhibitory Effects of (—)‐Epigallocatechin Gallate on Spontaneous Hepatoma in C3H/HeNCrj Mice and Human Hepatoma‐derived PLC/PRF/5 CellsJapanese Journal of Cancer Research, 1994